Maharashtra to start spot tests to find spurious medicines | Pune News
Maharashtra health minister Prakash Abitkar during his meeting with senior state health department officials in Mumbai on Wednesday…
Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention
The Karnataka Government during the recent inspection on the Hospitals treating cancer where high cost drugs are used…
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy Endpoints NewsTrevogrumab cuts semaglutide-induced lean mass loss by…
Why sharing your pills can harm your health, Gauteng Health warns
Gauteng health officials urged residents not to share prescribed medicines, even when symptoms look alike. The Gauteng Department…
Lilly’s oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease
In post-hoc analyses of ATTAIN-1, Foundayo 17.2 mg was associated with a predicted 57% and 18% reduction in…
This Precise Pill Cutter Makes Splitting Meds So Much Easier
Between daily supplements and medications, my midlife pill arsenal has become extensive, and this seems to be the…
Why Some Psychiatrists Prescribe GLP-1s
Hilary, a 39-year-old in California, has had depression for about as long as she can remember, which means…
Major change for users of diltiazem 360 mg controlled-release capsules
A widely used heart medication is facing a supply change in Australia, with its 360 mg controlled-release capsule…
59-year-old dad claims Ozempic left him ‘permanently blind’ within days: What we know about vision loss due to GLP-1 and the lawsuits
59-year-old dad claims Ozempic left him ‘permanently blind’ within days: What we know about vision loss due to…
Dad claims he went suddenly, permanently blind from Ozempic — in one of hundreds of lawsuits against GLP-1 makers
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The…
New Easier-to-Use GLP-1 Pill Safe for the Heart, Study Says
Orforglipron (Foundayo) was able to claim cardiovascular safety based on the ACHIEVE-4 trial, though heart benefits remain unproven.…
Dad says he went permanently blind — in lawsuit against Ozempic makers
Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The…